로딩 중…
지수 로딩 중…
HANDOK Inc.
002390· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩7,670-1.67%
2026-06-19
Price Chart
HANDOK Inc.-33.30%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 105.57B KRW |
| Revenue | 550.69B KRW |
| Net Income | -3.10B KRW |
| Total Assets | 798.75B KRW |
| Net Assets | 267.90B KRW |
| Employees | 988 |
| Value | |
| P/B | 0.39x |
| P/S | 0.19x |
| EV/EBITDA | 80.88x |
| FCF Yield | -9.36% |
| Profitability | |
| ROE | -1.16% |
| ROA | -0.39% |
| Op. Margin | 1.03% |
| Revenue Growth | 12.98% |
| Financial Health | |
| Debt Ratio | 198.15% |
| Total Debt | 376.94B KRW |
| FCF | -9.88B KRW |
| Cash | 21.64B KRW |
| Current Ratio | 0.77x |
| Net Debt/EBITDA | 62.36x |
| Dividend | |
| Div. Yield | 2.56% |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | -33.30% |
| 1M Return | -14.78% |
| From 52W High | -43.02% |
| 1Y MDD | -38.56% |
| Trading | |
| Volume | 20,233 shares |
| Foreign Own. | 2.39% |
| Per Share | |
| EPS | -219 KRW |
| BPS | 20,493 KRW |
Company Info
Handok, a pharmaceutical company established in 1954 and listed on the securities market in 1976, transferred its healthcare product business division to Handok Healthcare Co., Ltd. It manufactures and sells professional and general medicines, including diabetes treatments like Amaryl, Tenelia, and Lantus, and hypertension treatments such as Aprovasc, Aprovel, and Coaprovel. The company also engages in medical device and diagnostic reagent sales, pharmaceutical contract manufacturing and quality control services, and real estate leasing. Handok is headquartered in Gangnam-gu, Seoul Metropolitan City.